EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders

Julia Gallucci, Ju-Chi Yu, Lindsay D Oliver, Hajer Nakua, Peter Zhukovsky, Erin W Dickie, Zafiris J Daskalakis, George Foussias, Daniel M Blumberger, Colin Hawco, Aristotle N Voineskos

American Journal of Psychiatry · 01.10.2024 · 181 (10) · 910-919

DOI: 10.1176/appi.ajp.20230655 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Psychiatry, erschienen am 01.10.2024. Verfasst von Julia Gallucci und 10 weiteren Autor:innen. Beteiligte Einrichtung: Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto (Gallucci, Yu, Oliver, Nakua, Zhukovsky, Dickie, Fo…. Hauptthemen laut MEDLINE: Schizophrenia, Transcranial Magnetic Stimulation, Depression, Magnetic Resonance Imaging. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Conceptual similarities between depressive and negative symptoms complicate biomarker and intervention development. This study employed a data-driven approach to delineate the neural circuitry underlying depressive and negative symptoms in schizophrenia spectrum disorders (SSDs). METHODS: Data from three studies were analyzed (157 participants with SSDs) to assess brain-behavior relationships: two neuroimaging studies and a randomized trial of repetitive transcranial magnetic stimulation (rTMS). Partial least squares correlation (PLSC) was used to investigate associations between resting-state functional connectivity and depressive and negative symptoms. Secondary analyses of rTMS trial data (active, N=37; sham, N=33) were used to assess relationships between PLSC-derived symptom profiles and treatment outcomes. RESULTS: PLSC identified three latent variables (LVs) relating functional brain circuitry with symptom profiles. LV1 related a general depressive symptom factor with positive associations between and within the default mode network (DMN), the frontoparietal network (FPN), and the cingulo-opercular network (CON). LV2 related negative symptoms (no depressive symptoms) via negative associations, especially between the FPN and the CON, but also between the DMN and the FPN and the CON. LV3 related a guilt and early wakening depression factor via negative rather than positive associations with the DMN, FPN, and CON. The secondary visual network had a positive association with general depressive symptoms and negative associations with guilt and negative symptoms. Active (but not sham) rTMS applied bilaterally to the dorsolateral prefrontal cortex (DLPFC) reduced general depressive but not guilt-related or negative symptoms. CONCLUSIONS: The results clearly differentiate the neural circuitry underlying depressive and negative symptoms, and segregated across the two-factor structure of depression in SSDs. These findings support divergent neurobiological pathways of depressive symptoms and negative symptoms in people with SSDs. As treatment options are currently limited, bilateral rTMS to the DLPFC is worth exploring further for general depressive symptoms in people with SSDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaTranscranial Magnetic StimulationDepressionMagnetic Resonance ImagingHumansMaleFemaleAdultMiddle AgedNerve NetBrainDefault Mode Network

Stichwörter der Autor:innen

Depressive SymptomsNegative SymptomsNeurocircuitryNeurostimulationSchizophrenia Spectrum and Other Psychotic DisordersTranscranial Magnetic Stimulation

Autor:innen und Institutionen

  • Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto (Gallucci, Yu, Oliver, Nakua, Zhukovsky, Dickie, Foussias, Blumberger, Hawco, Voineskos); Institute of Medical Science, U…

Zitieren

APA

Gallucci, J., Yu, J. C., Oliver, L. D., Nakua, H., Zhukovsky, P., Dickie, E. W., Daskalakis, Z. J., Foussias, G., Blumberger, D. M., Hawco, C., & Voineskos, A. N. (2024). Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders. American Journal of Psychiatry, 181(10), 910-919. https://doi.org/10.1176/appi.ajp.20230655

Vancouver

Gallucci J, Yu JC, Oliver LD, Nakua H, Zhukovsky P, Dickie EW, et al. Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders. American Journal of Psychiatry. 2024;181(10):910-919. doi:10.1176/appi.ajp.20230655

BibTeX
@article{Gallucci2024,
  author = {Gallucci, Julia and Yu, Ju-Chi and Oliver, Lindsay D and Nakua, Hajer and Zhukovsky, Peter and Dickie, Erin W and Daskalakis, Zafiris J and Foussias, George and Blumberger, Daniel M and Hawco, Colin and Voineskos, Aristotle N},
  title = {Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders},
  journal = {American Journal of Psychiatry},
  year = {2024},
  volume = {181},
  number = {10},
  pages = {910--919},
  doi = {10.1176/appi.ajp.20230655}
}
Kostenlos starten →